The stock price for Wave Life Sciences Ltd (WVE) currently stands at $9.76. The stock experienced a substantial increase in the last session, hitting $36.0 after starting at $9.76. The stock’s lowest price was $9.0 before closing at $8.91.
In terms of market performance, Wave Life Sciences Ltd had a fairly uneven. The highest value for the stock in the past year was $16.74 on 11/11/24, and the lowest value was recorded at $5.04 on 09/06/24.
52-week price history of WVE Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Wave Life Sciences Ltd’s current trading price is -41.68% away from its 52-week high, while its distance from the 52-week low is 93.65%. The stock’s price range during this period has spanned from $5.04 to $16.74. In the Healthcare sector, the Wave Life Sciences Ltd’s shares surpassed a trading volume of approximately 2.88 million for the day, which was noticeably higher compared to the average daily volume of 9.1.36 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Wave Life Sciences Ltd (WVE) has experienced a quarterly rise of 54.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.55B and boasts a workforce of 288 employees.
A Closer Look at Analysts’ Ratings for Wave Life Sciences Ltd
As of right now, 12 analysts are rating Wave Life Sciences Ltd as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.21, with a change in price of -0.31. Similarly, Wave Life Sciences Ltd recorded 1,529,016 in trading volume during the last 100 days, posting a change of -3.08%.
Examining WVE’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for WVE stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.09.
WVE Stock Stochastic Average
Today, Wave Life Sciences Ltd’s raw stochastic average for the past 50 days stands at 99.15%, indicating a rise from the raw stochastic average of the last 20 days, which was 98.57%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 86.03% and 71.48% respectively.
WVE Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 75.22%. However, over the past six months, we’ve seen a stronger performance of -9.63%. The price of WVE fallen by 21.85% over the last 30 days. And in the last five days, it has surged by 20.64%.
